Vivos Achieves Landmark FDA Clearance for Sleep Apnea Solution
Dentistry Today
DECEMBER 1, 2023
Vivos Therapeutics, Inc. (NASDAQ: VVOS), a prominent medical device and technology company specializing in developing and commercializing highly effective proprietary treatments for sleep-related breathing disorders, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the treatment of severe obstructive sleep apnea (OSA) in adults using Vivos’ removable CARE (Complete Airway Repositioning and/or Expansion) oral appliances.
Let's personalize your content